参考文献/References:
1 American Association for the Study of Liver Diseases, European Association for the Study of the Liver. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver DiseasesJ. J Hepatol, 2014, 61: 642-659.
2 Wang Y, Ma L, Yuan ZH, et al. Percutaneous thermal ablation combined with TACE versus TACE monotherapy in the treatment for liver cancer with hepatic vein tumor thrombus: a retrospective studyJ. PLoS One, 2018, 13: e0201525.
3 Yang B, Zheng B, Yang MN, et al. Liver resection versus transarterial chemoembolization for the initial treatment of Barcelona Clinic Liver Cancer stage B hepatocellular carcinomaJ. Hepatol Int, 2018, 12: 417-428.
4 刘?宓，钟银雪，王?伟，等.血清异常凝血酶原在肝细胞癌诊断中的疗效分析J.中国现代医学杂志， 2017， 27：90-93．
5 罗志坚．肝硬化对原发性肝癌患者行TACE术后临床表现及预后影响D.西宁：青海大学， 2018．
6 Zhang D, Liu Z, Yin X, et al. Prognostic value of PIVKA-Ⅱ in hepatocellular carcinoma patients receiving curative ablation: a systematic review and meta-analysisJ. Int J Biol Markers, 2018, 33: 266-274.
7 张?华，李永兴，毛顺露，等．血清VEGF、p53抗体和AFP对原发性肝细胞癌的诊断价值J.标记免疫分析与临床， 2013， 20：71-74．
8 Shanbhogue A, Karnad A, Prasad S. Tumor response evaluation in oncology: current updateJ. J Comput Assist Tomogr, 2010, 34: 479-484.
9 胡晓菲，於建鹏，王钢胜．PIVKA-Ⅱ和AFP在原发性肝癌中的诊断和疗效监测中的临床应用价值J.临床和实验医学杂志，2017， 16：1473-1476．
10 袁联文，唐 伟，周建平，等．肝癌组织中脱-γ-羧基凝血酶原的测定及意义J.世界华人消化杂志， 2006，14：45-49．
11 马?青，李?慧，刘?航，等．奥沙利铂介入治疗早中期原发性肝癌的疗效分析J．介入放射学杂志， 2019， 28：128-131．
12 宗迎迎，徐?浩，许?伟，等．经肝动脉化疗栓塞联合经皮微波消融序贯治疗早期肝癌的疗效及预后影响因素J．介入放射学杂志，2015， 24：210-214．
13 任?炜，杨?薇．射频消融治疗复发性肝癌疗效及预后因素分析J.介入放射学杂志， 2015， 23：923-927．
14 Hatanaka T, Kakizaki S, Shimada Y, et al. Early decreases in alpha-fetoprotein and des-gamma-carboxy prothrombin predict the antitumor effects of hepatic transarterial infusion chemotherapy with cisplatin （CDDP） powder in patients with advanced hepatocellular carcinomaJ. Intern Med, 2016, 55: 2163-2171.
相似文献/References:
[1]邢桃红,牛焕章,周媛媛,等. TACE联合索拉非尼治疗23例中晚期肝细胞肝癌的护理[J].介入放射学杂志,2014,(05):449.
XING Tao- hong,NIU Huan- zhang,ZHOU Yuan- yuan,et al. Nursing for patients with advanced hepatocellular carcinoma receiving transcatheter arterial chemoembolization combined with sorafenib： initial experience in 23 cases[J].journal interventional radiology,2014,(01):449.
[2]阿布都外力·吾布力卡斯穆,迪里木拉提·巴吾冬,任伟新. 巴塞罗那肝癌B期患者TACE治疗的预后及生存分析[J].介入放射学杂志,2014,(05):435.
ABUDUWAILI Obulikasimu,DILMURAT Bawudun,REN Wei- xin.. Transcatheter arterial chemoembolization for the treatment of Barcelona stage B hepatocellular carcinoma： analysis of the prognosis and survival[J].journal interventional radiology,2014,(01):435.
[3]杨柏帅,施裕新,袁 敏,等.TACE治疗既往有肝功能衰竭史肝癌患者七例[J].介入放射学杂志,2014,(09):805.
YANG Bo shuai,SHI Yu xin,YUAN Min,et al.TACE treatment for patients with inoperable hepatocellular carcinoma and hepatic failure history： initial experience in seven cases[J].journal interventional radiology,2014,(01):805.
[4]许 贇,沈 强,王 能,等.微波消融治疗＞70岁早期肝细胞肝癌患者效果分析[J].介入放射学杂志,2016,(04):332.
XU Yun,SHEN Qiang,WANG Neng,et al.Effect analysis of microwave ablation therapy for early hepatocellular carcinoma in patients over 70 years old[J].journal interventional radiology,2016,(01):332.
[5]杨柏帅,施裕新,袁 敏,等.终末期肾衰竭肝癌患者TACE术中应用洛铂治疗3例[J].介入放射学杂志,2016,(05):381.
YANG Bo- shuai,SHI Yu- xin,YUAN Min,et al.Transcatheter arterial chemoembolization using lobaplatin and lipiodol for the treatment of hepatocellular carcinoma associated with end- stage renal failure： report of three cases[J].journal interventional radiology,2016,(01):381.
[6]吴志远,丁晓毅,黄 蔚,等.门脉粒子支架联合载药微球栓塞治疗肝癌7例[J].介入放射学杂志,2017,(02):161.
WU Zhiyuan,DING Xiaoyi,HUANG Wei,et al.Portal 125I seed stent implantation combined with drug-loaded microsphere embolization for the treatment of HCC： initial results in 7 patients[J].journal interventional radiology,2017,(01):161.
[7]王 燕,王茂强,段 峰.索拉非尼治疗中晚期肝癌预后因素分析[J].介入放射学杂志,2017,(03):258.
WANG Yan,WANG Maoqiang,DUAN Feng.Prognostic factor analysis of moderate- advanced hepatocellular carcinoma treated with sorafenib [J].journal interventional radiology,2017,(01):258.
[8]余天柱,罗剑钧,颜志平.血管内近程放疗与序贯三维适形放疗治疗门静脉主干癌栓的疗效对比 [J].介入放射学杂志,2017,(09):787.
YU Tianzhu,LUO Jianjun,YAN Zhiping.Endovascular brachytherapy vs. sequential three- dimensional conformal radiotherapy for the treatment of main portal vein tumor thrombus： a comparative study[J].journal interventional radiology,2017,(01):787.
[9]贾中芝,顾晓诚,蒋国民.门静脉癌栓分型对肝细胞性肝癌治疗方法的选择及患者预后的影响 [J].介入放射学杂志,2017,(10):944.
JIA Zhongzhi,GU Xiaocheng,JIANG Guomin.The application of portal vein tumor thrombus classification in selecting therapeutic method for HCC patients and in estimating the prognosis[J].journal interventional radiology,2017,(01):944.
[10]刘璐璐,章浙伟,杨永波,等.CT灌注参数动脉增强分数值在评估肝癌TACE术后疗效中的初步研究 [J].介入放射学杂志,2017,(11):988.
LIU Lulu,ZHANG Zhewei,YANG Yongbo,et al.Application of quantitative arterial enhancement fraction of multiphase perfusion CT imaging in evaluating the curative effect of transcatheter arterial chemoembolization for hepatocellular carcinoma[J].journal interventional radiology,2017,(01):988.